找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell and Gene Therapies; Miguel-Angel Perales,Syed A. Abutalib,Catherine Bo Book 2019 Springer Nature Switzerland AG 2019 Chimeric antigen

[復(fù)制鏈接]
11#
發(fā)表于 2025-3-23 11:26:37 | 只看該作者
12#
發(fā)表于 2025-3-23 16:47:20 | 只看該作者
13#
發(fā)表于 2025-3-23 20:25:18 | 只看該作者
Gene Therapy for Neoplastic Hematology in Transplant Setting the only therapy that has proven to be curative for hematological malignancies. The search for a more specific and, hopefully, less toxic therapeutic approach using immune system cells that are redirected toward the target of interest is needed and ongoing. This could be potentially accomplished by
14#
發(fā)表于 2025-3-24 01:05:14 | 只看該作者
15#
發(fā)表于 2025-3-24 04:33:59 | 只看該作者
Miguel-Angel Perales,Syed A. Abutalib,Catherine BoAddresses key clinically relevant issues across the full spectrum of cell and gene therapies.Draws attention to the availability and implications of high-impact clinical trials.Assists trainee and pra
16#
發(fā)表于 2025-3-24 08:59:36 | 只看該作者
17#
發(fā)表于 2025-3-24 13:39:26 | 只看該作者
https://doi.org/10.1007/978-3-319-54368-0Chimeric antigen receptor-T cells; Cytotoxic T cells for infections; Tumor infiltrating lymphocytes; De
18#
發(fā)表于 2025-3-24 16:51:26 | 只看該作者
Springer Nature Switzerland AG 2019
19#
發(fā)表于 2025-3-24 19:20:32 | 只看該作者
https://doi.org/10.1057/978-1-137-57085-7anked blood. Since then technological advances have made it possible to break down the therapeutic elements of fresh blood into their constituent platelets, red cells, plasma, and clotting factors, and through apheresis, blood bankers can even provide granulocytes, lymphocytes, progenitors, and stem
20#
發(fā)表于 2025-3-25 02:57:01 | 只看該作者
Bayreuth: Capital and Anti-capitalpidly evolving field of translational medicine. This approach has delivered exciting responses for some patients with lymphoid hematologic neoplasms, leading to recent US Food and Drug Administration approvals. Hematopoietic stem cellular gene therapy has also shown promising advances, with durable
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 18:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
诸城市| 瑞金市| 舒兰市| 临湘市| 隆回县| 界首市| 龙川县| 恩平市| 泰顺县| 剑阁县| 莎车县| 英吉沙县| 张家口市| 宾阳县| 南投市| 贵港市| 巴楚县| 洞头县| 德安县| 镇原县| 大宁县| 缙云县| 德兴市| 绵竹市| 文水县| 临泉县| 兴和县| 德清县| 彭泽县| 新巴尔虎左旗| 甘洛县| 光山县| 南溪县| 华亭县| 武乡县| 邯郸市| 财经| 敦煌市| 眉山市| 双流县| 察哈|